Allopurinol
Product Images NDC 53002-4821

3 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 53002-4821). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Allopurinol Structural Formula (Image 1)

Allopurinol Structural Formula (Image 1)
Chemical structure of Allopurinol displaying its molecular framework with nitrogen, carbon, hydrogen, and oxygen atoms connected by single and double bonds as typically represented in organic chemistry diagrams.*
FDA Label Image

Allopurinol Is A Structural Analogue Of The Natural Purine Base, Hypoxanthine. It Is An Inhibitor Of Xanthine Oxidase, The Enzyme Responsible For The Conversion Of Hypoxanthine To Xanthine And Of Xanthine To Uric Acid, The End Product Of Purine Metabolism In Man. Allopurinol Is Metabolized To The Corresponding Xanthine Analogue, Oxipurinol (alloxanthine), Which Also Is An Inhibitor Of Xanthine Oxidase. (Image 2)

Allopurinol Is A Structural Analogue Of The Natural Purine Base, Hypoxanthine. It Is An Inhibitor Of Xanthine Oxidase, The Enzyme Responsible For The Conversion Of Hypoxanthine To Xanthine And Of Xanthine To Uric Acid, The End Product Of Purine Metabolism In Man. Allopurinol Is Metabolized To The Corresponding Xanthine Analogue, Oxipurinol (alloxanthine), Which Also Is An Inhibitor Of Xanthine Oxidase. (Image 2)
Chemical structure diagram illustrating the molecular structures and interconversion pathways of Allopurinol, Oxipurinol, Hypoxanthine, Xanthine, and Uric Acid. The image depicts chemical formulas and arrows showing biochemical transformations among these compounds.*
FDA Label Image

Label Image (Lbl530024821)

Label Image (Lbl530024821)
Allopurinol 300 mg tablets label from RPK Pharmaceuticals, Inc., for a package of 30 tablets. The label instructs to take one tablet daily or as directed, includes barcode and NDC 53002-4821, with spaces for patient and prescriber information. The label mentions storage instructions and lot number details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.